Menu
GWAS Study

Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank.

Oliveri A, Rebernick RJ, Kuppa A et al.

38200128 PubMed ID
GWAS Study Type
402398 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

OA
Oliveri A
RR
Rebernick RJ
KA
Kuppa A
PA
Pant A
CY
Chen Y
DX
Du X
CK
Cushing KC
BH
Bell HN
RC
Raut C
PP
Prabhu P
CV
Chen VL
HB
Halligan BD
SE
Speliotes EK
Chapter II

Abstract

Summary of the research findings

Insulin resistance (IR) is a well-established risk factor for metabolic disease. The ratio of triglycerides to high-density lipoprotein cholesterol (TG:HDL-C) is a surrogate marker of IR. We conducted a genome-wide association study of the TG:HDL-C ratio in 402,398 Europeans within the UK Biobank. We identified 369 independent SNPs, of which 114 had a false discovery rate-adjusted P value < 0.05 in other genome-wide studies of IR making them high-confidence IR-associated loci. Seventy-two of these 114 loci have not been previously associated with IR. These 114 loci cluster into five groups upon phenome-wide analysis and are enriched for candidate genes important in insulin signaling, adipocyte physiology and protein metabolism. We created a polygenic-risk score from the high-confidence IR-associated loci using 51,550 European individuals in the Michigan Genomics Initiative. We identified associations with diabetes, hyperglyceridemia, hypertension, nonalcoholic fatty liver disease and ischemic heart disease. Collectively, this study provides insight into the genes, pathways, tissues and subtypes critical in IR.

402,398 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

402398
Total Participants
GWAS
Study Type
No
Replicated
European, African American or Afro-Caribbean, East Asian, South Asian
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.